Global Suppression of IL-6-induced Acute Phase Response Gene Expression after Chronic in Vivo Treatment with the Peroxisome Proliferator-activated Receptor-α Activator Fenofibrate

Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism

Desvergne, B., & Wahli, W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.5.0380 · Cited by 3,079 · see citing works

Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway

HEINRICH, P. C., BEHRMANN, I., MÜLLER-NEWEN, G., SCHAPER, F., & GRAEVE, L. (1998) · Biochemical Journal · doi:10.1042/bj3340297 · Cited by 2,130 · see citing works

Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?

Yudkin, J. S., Kumari, M., Humphries, S. E., & Mohamed-Ali, V. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00463-3 · Cited by 1,775 · see citing works

Gp130 and the interleukin-6 family of cytokines.

Taga, T., & Kishimoto, T. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.797 · Cited by 1,603 · see citing works

Inflammation, Pravastatin, and the Risk of Coronary Events After Myocardial Infarction in Patients With Average Cholesterol Levels

Ridker, P. M., Rifai, N., Pfeffer, M. A., Sacks, F. M., Moye, L. A., Goldman, S., Flaker, G. C., & Braunwald, E. (1998) · Circulation · doi:10.1161/01.cir.98.9.839 · Cited by 1,389 · see citing works

The PPARα–leukotriene B4 pathway to inflammation control

Devchand, P. R., Keller, H., Peters, J. M., Vazquez, M., Gonzalez, F. J., & Wahli, W. (1996) · Nature · doi:10.1038/384039a0 · Cited by 1,345 · see citing works

Tissue-specific in vitro transcription from the mouse albumin promoter

Gorski, K., Carneiro, M., & Schibler, U. (1986) · Cell · doi:10.1016/0092-8674(86)90519-2 · Cited by 1,316 · see citing works

Novel Risk Factors for Systemic Atherosclerosis

Ridker, P. M., Stampfer, M. J., & Rifai, N. (2001) · JAMA · doi:10.1001/jama.285.19.2481 · Cited by 1,300 · see citing works

Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators

Staels, B., Köenig, W., Habib, A., Merval, R., Lebret, M., Pineda‐Torra, I., Delerive, P., Fadel, A., Chinetti, G., Fruchart, J., et al. (1998) · Nature · doi:10.1038/31701 · Cited by 1,134 · see citing works

Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1

Delerive, P., De Bosscher, K., Besnard, S., Vanden Berghe, W., Peters, J. M., Gonzalez, F. J., Fruchart, J.-C., Tedgui, A., Haegeman, G., & Staels, B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32048 · Cited by 1,089 · see citing works

Biological Role of the CCAAT/Enhancer-binding Protein Family of Transcription Factors

Lekstrom-Himes, J., & Xanthopoulos, K. G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.44.28545 · Cited by 801 · see citing works

Peroxisome proliferator-activated receptors in inflammation control

Delerive, P., Fruchart, J., & Staels, B. (2001) · Journal of Endocrinology · doi:10.1677/joe.0.1690453 · Cited by 755 · see citing works

Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders.

Yoshida, K., Taga, T., Saito, M., Suematsu, S., Kumanogoh, A., Tanaka, T., Fujiwara, H., Hirata, M., Yamagami, T., Nakahata, T., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.407 · Cited by 634 · see citing works

PPARα Activators Inhibit Cytokine-Induced Vascular Cell Adhesion Molecule-1 Expression in Human Endothelial Cells

Marx, N., Sukhova, G. K., Collins, T., Libby, P., & Plutzky, J. (1999) · Circulation · doi:10.1161/01.cir.99.24.3125 · Cited by 597 · see citing works

Induction of IκBα Expression as a Mechanism Contributing to the Anti-inflammatory Activities of Peroxisome Proliferator-activated Receptor-α Activators

Gervois, P. P., Fruchart, J., Delerive, P., & Staels, B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004045200 · Cited by 457 · see citing works

Hepatic response to sepsis: Interaction between coagulation and inflammatory processes

Dhainaut, J.-F., Marin, N., Mignon, A., & Vinsonneau, C. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107001-00016 · Cited by 361 · see citing works

Cooperative transcriptional activity of Jun and Stat3 beta, a short form of Stat3.

Schaefer, T. S., Sanders, L. K., & Nathans, D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9097 · Cited by 357 · see citing works

PPAR Activators as Antiinflammatory Mediators in Human T Lymphocytes

Marx, N., Kehrle, B., Kohlhammer, K., Grüb, M., Köenig, W., Hombach, V., Libby, P., & Plutzky, J. (2002) · Circulation Research · doi:10.1161/01.res.0000014225.20727.8f · Cited by 331 · see citing works

Essential Role of STAT3 in the Control of the Acute-Phase Response as Revealed by Inducible Gene Activation in the Liver

Alonzi, T., Maritano, D., Gorgoni, B., Rizzuto, G., Libert, C., & Poli, V. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.5.1621-1632.2001 · Cited by 329 · see citing works

STAT3 participates in transcriptional activation of the C-reactive protein gene by interleukin-6

Zhang, D., Sun, M., Samols, D., & Kushner, I. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.16.9503 · Cited by 309 · see citing works

Regulation of Lipid and Lipoprotein Metabolism by PPAR Activators

Gervois, P. P., Pineda‐Torra, I., Fruchart, J., & Staels, B. (2000) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2000.002 · Cited by 289 · see citing works

Dual Signaling Role of the Protein Tyrosine Phosphatase SHP-2 in Regulating Expression of Acute-Phase Plasma Proteins by Interleukin-6 Cytokine Receptors in Hepatic Cells

Kim, H., & Baumann, H. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.8.5326 · Cited by 170 · see citing works

Severe hypertriglyceridemia with insulin resistance is associated with systemic inflammation: reversal with bezafibrate therapy in a randomized controlled trial

Jonkers, I. J. A. M., Mohrschladt, M. F., Westendorp, R. G. J., van der Laarse, A., & Smelt, A. H. M. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)01123-8 · Cited by 166 · see citing works

Negative Regulation of Human Fibrinogen Gene Expression by Peroxisome Proliferator-activated Receptor α Agonists via Inhibition of CCAAT Box/Enhancer-binding Protein β

Gervois, P. P., Vu‐Dac, N., Kleemann, R., Kockx, M., Dubois, G., Laine, B., Kosykh, V., Fruchart, J., Kooistra, T., & Staels, B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102839200 · Cited by 153 · see citing works

Fibrates Suppress Fibrinogen Gene Expression in Rodents Via Activation of the Peroxisome Proliferator-Activated Receptor-

Kockx, M., Gervois, P. P., Poulain, P., Derudas, B., Peters, J. M., Gonzalez, F. J., Princen, H. M. G., Kooistra, T., & Staels, B. (1999) · Blood · doi:10.1182/blood.v93.9.2991 · Cited by 139 · see citing works

Vascular Inflammation Is Negatively Autoregulated by Interaction Between CCAAT/Enhancer-Binding Protein-δ and Peroxisome Proliferator-Activated Receptor-γ

Takata, Y., Kitami, Y., Yang, Z., Nakamura, M., Okura, T., & Hiwada, K. (2002) · Circulation Research · doi:10.1161/01.res.0000031271.20771.4f · Cited by 130 · see citing works

Role of CAAT-enhancer binding protein isoforms in the cytokine regulation of acute-phase plasma protein genes.

Baumann, H., Morella, K. K., Campos, S. P., Cao, Z. D., & Jahreis, G. P. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41838-8 · Cited by 127 · see citing works

Role of novel markers of inflammation in patients with stable coronary heart disease

Hoffmeister, A. C., Rothenbacher, D., Bäzner, U. M., Fröhlich, M., Brenner, H., Hombach, V., & Köenig, W. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01355-2 · Cited by 96 · see citing works

[22] Isolation and analysis of nuclear RNA

Nevins, J. R. (1987) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(87)52025-0 · Cited by 91 · see citing works

Perturbation of developmental gene expression in rat liver by fibric acid derivatives: lipoprotein lipase and α-fetoprotein as models

Staels, B., & Auwerx, J. H. (1992) · Development · doi:10.1242/dev.115.4.1035 · Cited by 76 · see citing works

c-Jun AND c-Fos COOPERATE WITH STAT3 IN IL-6-INDUCED TRANSACTIVATION OF THE IL-6 RESPONSE ELEMENT (IRE)

Schuringa, J. J., Timmer, H., Luttickhuizen, D., Vellenga, E., & Kruijer, W. (2001) · Cytokine · doi:10.1006/cyto.2001.0856 · Cited by 70 · see citing works

Smad Proteins Suppress CCAAT/Enhancer-binding Protein (C/EBP) β- and STAT3-mediated Transcriptional Activation of the Haptoglobin Promoter

Zauberman, A., Lapter, S., & Zipori, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005813200 · Cited by 65 · see citing works

Synergistic Activity of STAT3 and c-Jun at a Specific Array of DNA Elements in the α2-Macroglobulin Promoter

Yoo, J.-Y., Wang, W., Desiderio, S. V., & Nathans, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009935200 · Cited by 65 · see citing works

The role of Stat and C/EBP transcription factors in the synergistic activation of rat serine protease inhibitor-3 gene by interleukin-6 and dexamethasone

Kordula, T., & Travis, J. W. (1996) · Biochemical Journal · doi:10.1042/bj3131019 · Cited by 50 · see citing works

Effect of Ciprofibrate on C-Reactive Protein and Fibrinogen Levels

Rizos, E., Kostoula, A., Elisaf, M., & Mikhailidis, D. P. (2002) · Angiology · doi:10.1177/000331970205300304 · Cited by 47 · see citing works

Functional Analysis of IL‐6 and IL‐6DBP/C/EBPβ by Gene Targeting

Fattori, E., Sellitto, C., Cappelletti, M., LAllARO, D., Bellavia, D., Screpanti, I., Gulino, A., Costantini, F. D., & Poli, V. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb32331.x · Cited by 14 · see citing works

A viscometric method of measuring plasma fibrinogen concentrations.

Ernst, E., Resch, K. L., Saradeth, T., Maier, A., & Mátrai, Á. (1992) · Journal of Clinical Pathology · doi:10.1136/jcp.45.6.534 · Cited by 9 · see citing works

Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease

Pawlak, M., Lefebvre, P., & Staels, B. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.10.039 · Cited by 1,578 · see citing works

Peroxisome Proliferator-Activated Receptor Alpha Target Genes

Rakhshandehroo, M., Knoch, B., Müller, M., & Kersten, S. (2010) · PPAR Research · doi:10.1155/2010/612089 · Cited by 1,020 · see citing works

Sorting out the roles of PPAR  in energy metabolism and vascular homeostasis

Lefebvre, P. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27989 · Cited by 962 · see citing works

Ppars are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation

Varga, T., Czimmerer, Z., & Nagy, L. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.02.014 · Cited by 933 · see citing works

Molecular Actions of PPARα in Lipid Metabolism and Inflammation

Bougarne, N., Weyers, B., Desmet, S. J., Deckers, J., Ray, D. W., Staels, B., & De Bosscher, K. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00064 · Cited by 898 · see citing works

PPARs and molecular mechanisms of transrepression

Ricote, M., & Glass, C. K. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.02.013 · Cited by 572 · see citing works

Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms

Straus, D. S., & Glass, C. K. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.09.003 · Cited by 553 · see citing works

Suppression of hepcidin during anemia requires erythropoietic activity

Pak, M., Lopez, M. A., Gabayan, V., Ganz, T., & Rivera, S. (2006) · Blood · doi:10.1182/blood-2006-06-028787 · Cited by 472 · see citing works

The role and regulation of the peroxisome proliferator activated receptor alpha in human liver

Kersten, S., & Stienstra, R. (2017) · Biochimie · doi:10.1016/j.biochi.2016.12.019 · Cited by 397 · see citing works

Molecular pathways in non-alcoholic fatty liver disease

Auguet, T., Berlanga, A., Guiu‐Jurado, E., & Porras, J. A. (2014) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s62831 · Cited by 380 · see citing works

Nutrition-induced ketosis alters metabolic and signaling gene networks in liver of periparturient dairy cows

Loor, J. J., Everts, R. E., Bionaz, M., Dann, H. M., Morin, D. E., Oliveira, R., Rodriguez‐Zas, S. L., Drackley, J. K., & Lewin, H. A. (2007) · Physiological Genomics · doi:10.1152/physiolgenomics.00188.2007 · Cited by 366 · see citing works

Evaluation of C-Reactive Protein Measurement for Assessing the Risk and Prognosis in Ischemic Stroke

Napoli, M. D., Schwaninger, M., Cappelli, R., Ceccarelli, E., Gianfilippo, G. D., Donati, C., Emsley, H. C. A., Forconi, S., Hopkins, S. J., Masotti, L., et al. (2005) · Stroke · doi:10.1161/01.str.0000165929.78756.ed · Cited by 288 · see citing works

PPARs, Obesity, and Inflammation

Stienstra, R., Duval, C., Müller, M., & Kersten, S. (2007) · PPAR Research · doi:10.1155/2007/95974 · Cited by 287 · see citing works

Roles of PPARs in NAFLD: Potential therapeutic targets

Tailleux, A., Wouters, K., & Staels, B. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.10.016 · Cited by 283 · see citing works

Nuclear receptors and nonalcoholic fatty liver disease

Cave, M. C., Clair, H. B., Hardesty, J., Falkner, K. C., Feng, W., Clark, B. J., Sidey, J., Shi, H., Aqel, B. A., McClain, C. J., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2016.03.002 · Cited by 280 · see citing works

Mitochondrial Quality Control as a Therapeutic Target

Suliman, H. B., & Piantadosi, C. A. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.011502 · Cited by 265 · see citing works

Cholesterol crystal induced arterial inflammation and destabilization of atherosclerotic plaque

Janoudi, A., Shamoun, F. E., Kalavakunta, J. K., & Abela, G. S. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv653 · Cited by 242 · see citing works

The G0/G1 switch gene 2 is a novel PPAR target gene

Zandbergen, F. J., Mandard, S., Escher, P., Tan, N. S., Patsouris, D., Jatkoe, T., Rojas-Caro, S., Madore, S., Wahli, W., Tafuri, S. R., et al. (2005) · Biochemical Journal · doi:10.1042/bj20050636 · Cited by 228 · see citing works

Niacin and fibrates in atherogenic dyslipidemia: pharmacotherapy to reduce cardiovascular risk

Chapman, M. J., Redfern, J. S., McGovern, M. E., & Giral, P. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.01.008 · Cited by 227 · see citing works

Comprehensive Analysis of PPAR α -Dependent Regulation of Hepatic Lipid Metabolism by Expression Profiling

Rakhshandehroo, M., Sanderson, L. M., Heinäniemi, M., Stienstra, R., Carlberg, C., de Groot, P. J., Müller, M. M., & Kersten, S. (2007) · PPAR Research · doi:10.1155/2007/26839 · Cited by 224 · see citing works

PPARα in atherosclerosis and inflammation

Zandbergen, F. J., & Plutzky, J. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.04.021 · Cited by 215 · see citing works

Peroxisome Proliferator-Activated Receptor α Protects against Obesity-Induced Hepatic Inflammation

Stienstra, R., Mandard, S., Patsouris, D., Maass, C., Kersten, S., & Müller, M. M. (2007) · Endocrinology · doi:10.1210/en.2007-0014 · Cited by 191 · see citing works

Protective Effects of (E)-β-Caryophyllene (BCP) in Chronic Inflammation

Scandiffio, R., Geddo, F., Cottone, E., Querio, G., Antoniotti, S., Gallo, M. P., Maffei, M. E., & Bovolin, P. (2020) · Nutrients · doi:10.3390/nu12113273 · Cited by 181 · see citing works

Modulation of Hepatic Inflammatory Risk Markers of Cardiovascular Diseases by PPAR–α Activators

Zambon, A., Gervois, P. P., Pauletto, P., Fruchart, J., & Staels, B. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000204327.96431.9a · Cited by 162 · see citing works

Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors

Gervois, P. P., Fruchart, J., & Staels, B. (2007) · Nature Clinical Practice Endocrinology &#38 Metabolism · doi:10.1038/ncpendmet0397 · Cited by 159 · see citing works

The Role of PPAR α Activation in Liver and Muscle

Burri, L., Thoresen, G. H., & Berge, R. K. (2010) · PPAR Research · doi:10.1155/2010/542359 · Cited by 159 · see citing works

PPARα ligands inhibit radiation-induced microglial inflammatory responses by negatively regulating NF-κB and AP-1 pathways

Ramanan, S., Kooshki, M., Zhao, W., Hsu, F., & Robbins, M. E. C. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.09.002 · Cited by 158 · see citing works

PPARα inhibits vascular smooth muscle cell proliferation underlying intimal hyperplasia by inducing the tumor suppressor p16INK4a

Gizard, F., Amant, C., Barbier, O., Bellosta, S., Robillard, R., Percevault, F., Sevestre, H., Krimpenfort, P., Corsini, A., Rochette, J., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci22756 · Cited by 159 · see citing works

Time-Resolved and Tissue-Specific Systems Analysis of the Pathogenesis of Insulin Resistance

Kleemann, R., van Erk, M., Verschuren, L., van den Hoek, A. M., Koek, M., Wielinga, P. Y., Jie, A., Pellis, L., Bobeldijk-Pastorova, I., Kelder, T., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008817 · Cited by 146 · see citing works

The connection between C‐reactive protein and atherosclerosis

Singh, S. K., Suresh, M. V., Voleti, B., & Agrawal, A. C. (2008) · Annals of Medicine · doi:10.1080/07853890701749225 · Cited by 139 · see citing works

Major urinary protein-1 increases energy expenditure and improves glucose intolerance through enhancing mitochondrial function in skeletal muscle of diabetic mice

Hui, X., Zhu, W., Wang, Y., Lam, K. S. L., Zhang, J., Wu, D., Kraegen, E. W., Li, Y., & Xu, A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.001107 · Cited by 130 · see citing works

Inflammation in Diabetes Mellitus: Role of Peroxisome Proliferator-Activated Receptor–α and Peroxisome Proliferator-Activated Receptor–γ Agonists

Libby, P., & Plutzky, J. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.11.004 · Cited by 127 · see citing works

Cardiac-Specific Overexpression of Peroxisome Proliferator–Activated Receptor-α Causes Insulin Resistance in Heart and Liver

Park, S., Cho, Y.-R., Finck, B. N., Kim, H.-J., Higashimori, T., Hong, E., Lee, M., Danton, C., Deshmukh, S. D., Cline, G. W., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.9.2514 · Cited by 119 · see citing works

Enhanced expression and activation of pro-inflammatory transcription factors distinguish aneurysmal from atherosclerotic aorta: IL-6- and IL-8-dominated inflammatory responses prevail in the human aneurysm

Lindeman, J. H. N., Abdul-Hussien, H., Schaapherder, A. F., van Bockel, J. H., von der Thüsen, J. H., Roelen, D. L., & Kleemann, R. (2008) · Clinical Science · doi:10.1042/cs20070352 · Cited by 118 · see citing works

Treating NASH by targeting peroxisome proliferator-activated receptors

Staels, B., Butruille, L., & Francque, S. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.07.004 · Cited by 110 · see citing works

Sodium Butyrate Ameliorates High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease through Peroxisome Proliferator-Activated Receptor α-Mediated Activation of β Oxidation and Suppression of Inflammation

Sun, B., Jia, Y., Hong, J., Sun, Q., Gao, S., Hu, Y., Zhao, N., & Zhao, R. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b01189 · Cited by 106 · see citing works

Gene expression profiling in the lung and liver of PFOA-exposed mouse fetuses

Rosen, M. B., Thibodeaux, J. R., Wood, C. R., ZEHR, R. D. J., Schmid, J. E., & Lau, C. S. (2007) · Toxicology · doi:10.1016/j.tox.2007.06.095 · Cited by 107 · see citing works

Evaluation of chronic toxicity and carcinogenicity of ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate in Sprague–Dawley rats

Caverly Rae, J. M., Craig, L., Slone, T. W., Frame, S. R., Buxton, L. W., & Kennedy, G. L. (2015) · Toxicology Reports · doi:10.1016/j.toxrep.2015.06.001 · Cited by 102 · see citing works

DAP12 (KARAP) amplifies inflammation and increases mortality from endotoxemia and septic peritonitis

Turnbull, I. R., McDunn, J. E., Takai, T., Townsend, R. R., Cobb, J. P., & Colonna, M. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050986 · Cited by 99 · see citing works

Role of adipose triglyceride lipase (PNPLA2) in protection from hepatic inflammation in mouse models of steatohepatitis and endotoxemia

Jha, P., Claudel, T., Baghdasaryan, A., Mueller, M., Halilbasic, E., Das, S. K., Lass, A., Zimmermann, R., Zechner, R., Höefler, G., et al. (2013) · Hepatology · doi:10.1002/hep.26732 · Cited by 96 · see citing works

Fenofibrate, a peroxisome proliferator-activated receptor α agonist, exerts neuroprotective effects in traumatic brain injury

Besson, V. C., Chen, X. R., Plotkine, M., & Marchand‐Leroux, C. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.06.019 · Cited by 96 · see citing works

Key points for the development of antioxidant cocktails to prevent cellular stress and damage caused by reactive oxygen species (ROS) during manned space missions

Gómez, X., Sanon, S., Zambrano, K., Asquel, S., Bassantes, M., Morales, J. E., Otáñez, G., Pomaquero, C., Villarroel, S., Zurita, A., et al. (2021) · npj Microgravity · doi:10.1038/s41526-021-00162-8 · Cited by 92 · see citing works

In utero and lactational exposure to BDE-47 promotes obesity development in mouse offspring fed a high-fat diet: impaired lipid metabolism and intestinal dysbiosis

Wang, D.-Z., Yan, J., Teng, M.-M., Yan, S., Zhou, Z.-Q., & Zhu, W. (2018) · Archives of Toxicology · doi:10.1007/s00204-018-2177-0 · Cited by 83 · see citing works

PPARα activators upregulate eNOS activity and inhibit cytokine-induced NF-κB activation through AMP-activated protein kinase activation

Okayasu, T., Tomizawa, A., Suzuki, K., Manaka, K., & Hattori, Y. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.02.002 · Cited by 91 · see citing works

Multi-omics analysis of multiple missions to space reveal a theme of lipid dysregulation in mouse liver

Beheshti, A., Chakravarty, K., Fogle, H., Fazelinia, H., Silveira, W. A. D., Boyko, V., Polo, S.-H. L., Saravia-Butler, A. M., Hardiman, G., Taylor, D., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-55869-2 · Cited by 90 · see citing works

Early antithrombotic and anti-inflammatory effects of simvastatin versus fenofibrate in patients with hypercholesterolemia

Undas, A., Celińska‐Löwenhoff, M., Domagała, T. B., Iwaniec, T., Dropiński, J., Löwenhoff, T., & Szczeklik, A. (2005) · Thrombosis and Haemostasis · doi:10.1160/th05-01-0067 · Cited by 90 · see citing works

Acyl-CoA Thioesterase 1 (ACOT1) Regulates PPARα to Couple Fatty Acid Flux With Oxidative Capacity During Fasting

Franklin, M. P., Sathyanarayan, A., & Mashek, D. G. (2017) · Diabetes · doi:10.2337/db16-1519 · Cited by 87 · see citing works

The impact of PPARα activation on whole genome gene expression in human precision cut liver slices

Janssen, A. W. F., Betzel, B., Stoopen, G. M., Berends, F. J., Janssen, I. M. C., Peijnenburg, A., & Kersten, S. (2015) · BMC Genomics · doi:10.1186/s12864-015-1969-3 · Cited by 82 · see citing works

Nuclear Control of the Inflammatory Response in Mammals by Peroxisome Proliferator-Activated Receptors

Mandard, S., & Patsouris, D. (2013) · PPAR Research · doi:10.1155/2013/613864 · Cited by 83 · see citing works

Transgenic Flavonoid Tomato Intake Reduces C-Reactive Protein in Human C-Reactive Protein Transgenic Mice More Than Wild-Type Tomato

Rein, D., Schijlen, E. G. W. M., Kooistra, T., Herbers, K., Verschuren, L., Hall, R. D., Sonnewald, U., Bovy, A. G., & Kleemann, R. (2006) · Journal of Nutrition · doi:10.1093/jn/136.9.2331 · Cited by 83 · see citing works

Endocannabinoid System in Hepatic Glucose Metabolism, Fatty Liver Disease, and Cirrhosis

Bazwinsky‐Wutschke, I., Zipprich, A., & Dehghani, F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102516 · Cited by 82 · see citing works

Fenofibrate Reduces Atherogenesis in ApoE*3Leiden Mice

Kooistra, T., Verschuren, L., der Weij, J. D. V.-V., Köenig, W., Toet, K. H., Princen, H. M. G., & Kleemann, R. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000238348.05028.14 · Cited by 78 · see citing works

Glycogen synthase 2 is a novel target gene of peroxisome proliferator-activated receptors

Mandard, S., Stienstra, R., Escher, P., Tan, N. S., Kim, I., Gonzalez, F. J., Wahli, W., Desvergne, B., Müller, M. M., & Kersten, S. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7006-1 · Cited by 77 · see citing works

Immune-regulation of the apolipoprotein A-I/C-III/A-IV gene cluster in experimental inflammation

Navarro, M. Á., Carpintero, R., Acı́n, S., Arbonés-Mainar, J. M., Calleja, L., Carnicer, R., Surra, J. C., Guzmán-García, M. A., González‐Ramón, N., Iturralde, M., et al. (2005) · Cytokine · doi:10.1016/j.cyto.2005.03.002 · Cited by 77 · see citing works

The Interleukin-1 receptor antagonist is a direct target gene of PPARα in liver

Stienstra, R., Mandard, S., Tan, N. S., Wahli, W., Trautwein, C., Richardson, T. A., Lichtenauer-Kaligis, E. G. R., Kersten, S., & Müller, M. M. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2006.11.019 · Cited by 75 · see citing works

Serum levels of perfluoroalkyl acids (PFAAs) with isomer analysis and their associations with medical parameters in Chinese pregnant women

Jiang, W., Zhang, Y., Zhu, L. Y., & Deng, J. (2013) · Environment International · doi:10.1016/j.envint.2013.12.001 · Cited by 74 · see citing works

Nervonic acid and its sphingolipids: Biological functions and potential food applications

Phung, N. V., Rong, F., Xia, W.-Y., Fan, Y., Li, X. Y., Wang, S. A., & Li, F. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2203753 · Cited by 72 · see citing works

Chronic dietary toxicity and carcinogenicity study with ammonium perfluorooctanoate in Sprague–Dawley rats

Butenhoff, J. L., Kennedy, G. L., Chang, S., & Olsen, G. W. (2012) · Toxicology · doi:10.1016/j.tox.2012.04.001 · Cited by 72 · see citing works

Inflammation, thrombosis and acute coronary syndromes

Carter, A. M. (2005) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2005.018 · Cited by 70 · see citing works

Peroxisome proliferator-activated receptors in the pathogenesis and therapies of liver fibrosis

Han, X., Wu, Y., Yang, Q., & Cao, G. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107791 · Cited by 71 · see citing works

Modulation of Airway Remodeling and Airway Inflammation by Peroxisome Proliferator-Activated Receptor γ in a Murine Model of Toluene Diisocyanate-Induced Asthma

Lee, K. S., Park, S. J., Kim, S. R., Min, K. H., Jin, S. M., Lee, H. K., & Lee, Y. C. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.8.5248 · Cited by 71 · see citing works

Systemic and Distal Repercussions of Liver-Specific Peroxisome Proliferator-Activated Receptor-α Control of the Acute-Phase Response

Mansouri, R. M., Baugé, E., Staels, B., & Gervois, P. P. (2008) · Endocrinology · doi:10.1210/en.2007-1339 · Cited by 62 · see citing works

CXCL9 and CXCL11 Chemokines Modulation by Peroxisome Proliferator-Activated Receptor-α Agonists Secretion in Graves’ and Normal Thyrocytes

Antonelli, A., Ferrari, S. M., Frascerra, S., Pupilli, C., Mancusi, C., Metelli, M. R., Orlando, C., Ferrannini, E., & Fallahi, P. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0923 · Cited by 61 · see citing works

Insights into the Role of PPARβ/δ in NAFLD

Chen, J., Montagner, A., Tan, N. S., & Wahli, W. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071893 · Cited by 60 · see citing works

Hypoalbuminemia Predicts Acute Stroke Mortality: Paul Coverdell Georgia Stroke Registry

Famakin, B. M., Weiss, P., Hertzberg, V., McClellan, W., Presley, R. J., Krompf, K., Karp, H. R., & Frankel, M. (2009) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2009.01.015 · Cited by 59 · see citing works

Anti-inflammatory role of fenofibrate in treating diseases

Jin, L., Hu, H., Ji, Y., Jia, Z., Peng, M., & Huang, S. (2023) · Biomolecules and Biomedicine · doi:10.17305/bb.2022.8534 · Cited by 58 · see citing works

Fenofibrate: a novel formulation (Triglide?) in the treatment of lipid disorders: a review

Τζιόμαλος, Κ., & Athyros, V. G. (2006) · International Journal of Nanomedicine · doi:10.2147/nano.2006.1.2.129 · Cited by 58 · see citing works

Lipids as targets for novel anti-inflammatory therapies

Huwiler, A., & Pfeilschifter, J. M. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.06.008 · Cited by 57 · see citing works

Fenofibrate Improves Liver Function and Reduces the Toxicity of the Bile Acid Pool in Patients With Primary Biliary Cholangitis and Primary Sclerosing Cholangitis Who Are Partial Responders to Ursodiol

Ghonem, N. S., Auclair, A. M., Hemme, C. L., Gallucci, G. M., de la Rosa Rodriguez, R., Boyer, J. L., & Assis, D. N. (2020) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1930 · Cited by 57 · see citing works

PPARα as a therapeutic target in inflammation-associated diseases

Gervois, P. P., & Mansouri, R. M. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.715633 · Cited by 54 · see citing works

Unraveling the Complex Relationship Triad between Lipids, Obesity, and Inflammation

Khan, S. A., Ali, A., Khan, S. A., Zahran, S. A., Damanhouri, G. A., Azhar, E. I., & Qadri, I. (2014) · Mediators of Inflammation · doi:10.1155/2014/502749 · Cited by 52 · see citing works

Therapeutic Effects of Fenofibrate Nano-Emulsion Eye Drops on Retinal Vascular Leakage and Neovascularization

Huang, L., Liang, W., Zhou, K., Wassel, R. A., Ridge, Z., Ma, J., & Wang, B. (2021) · Biology · doi:10.3390/biology10121328 · Cited by 51 · see citing works

Peroxisome proliferator-activated receptors—from active regulators of macrophage biology to pharmacological targets in the treatment of cardiovascular disease

Bouhlel, M. A., Staels, B., & Chinetti‐Gbaguidi, G. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01892.x · Cited by 51 · see citing works

PPARs and their Effects on the Cardiovascular System

Oyekan, A. (2011) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2010.531845 · Cited by 51 · see citing works

Up-Regulation and Coexpression of MIF and Matrix Metalloproteinases in Human Abdominal Aortic Aneurysms

Verschuren, L., Lindeman, J. H. N., van Bockel, J. H., Abdul-Hussien, H., Kooistra, T., & Kleemann, R. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.1195 · Cited by 48 · see citing works

Vesicular Stomatitis Virus Expressing Tumor Suppressor p53 Is a Highly Attenuated, Potent Oncolytic Agent

Heiber, J. F., & Barber, G. N. (2011) · Journal of Virology · doi:10.1128/jvi.05408-11 · Cited by 46 · see citing works

Interleukin-6 Is Essential for Primary Resistance to Francisella tularensis Live Vaccine Strain Infection

Kurtz, S., Foreman, O., Bosio, C., Anver, M., & Elkins, K. (2012) · Infection and Immunity · doi:10.1128/iai.01249-12 · Cited by 45 · see citing works

Pleiotropic effects of fibrates

Chinetti, G., Fruchart, J., & Staels, B. (2005) · Current Atherosclerosis Reports · doi:10.1007/s11883-005-0053-x · Cited by 46 · see citing works

A Dietary Mixture Containing Fish Oil, Resveratrol, Lycopene, Catechins, and Vitamins E and C Reduces Atherosclerosis in Transgenic Mice1–3

Verschuren, L., Wielinga, P. Y., van Duyvenvoorde, W., Tijani, S., Toet, K. H., van Ommen, B., Kooistra, T., & Kleemann, R. (2011) · Journal of Nutrition · doi:10.3945/jn.110.133751 · Cited by 44 · see citing works

Liraglutide Alleviates Hepatic Steatosis and Liver Injury in T2MD Rats via a GLP-1R Dependent AMPK Pathway

Zhou, R., Lin, C., Cheng, Y., Zhuo, X., Li, Q., Xu, W., Zhao, L., & Yang, L. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.600175 · Cited by 44 · see citing works

Fenofibrate and PBA prevent fatty acid-induced loss of adiponectin receptor and pAMPK in human hepatoma cells and in hepatitis C virus-induced steatosis

Rahman, S. M., Qadri, I., Janssen, R. C., & Friedman, J. E. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m800633-jlr200 · Cited by 43 · see citing works

Fibrates upregulate TRB3 in lymphocytes independent of PPARα by augmenting CCAAT/enhancer-binding proteinβ (C/EBPβ) expression

Selim, E., Frkanec, J. T., & Cunard, R. A. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2006.06.006 · Cited by 44 · see citing works

Neutrophils as one of the major haptoglobin sources in mastitis affected milk

Lai, I.-H., Tsao, J. H., Lu, Y., Lee, J. W., Zhao, X., Chien, F. L., & Mao, S. J. T. (2008) · Veterinary Research · doi:10.1051/vetres:2008055 · Cited by 44 · see citing works

Statins and nitric oxide reduce C-reactive protein production while inflammatory conditions persist

Voleti, B., & Agrawal, A. C. (2005) · Molecular Immunology · doi:10.1016/j.molimm.2005.06.045 · Cited by 43 · see citing works

Inflammation, dyslipidaemia, diabetes and PPARs: pharmacological interest of dual PPARα and PPARγ agonists

Gervois, P. P., Fruchart, J., & Staels, B. (2004) · International Journal of Clinical Practice · doi:10.1111/j.1368-504x.2004.00376.x · Cited by 42 · see citing works

Hepatic gene expression changes in pigs experimentally infected with the lung pathogen Actinobacillus pleuropneumoniae as analysed with an innate immunity focused microarray

Skovgaard, K., Mortensen, S., Boyé, M., Hedegaard, J., & Heegaard, P. M. H. (2009) · Innate Immunity · doi:10.1177/1753425909342730 · Cited by 39 · see citing works

Feasibility and Clinical Significance of In Vivo Cholesterol Crystal Detection Using Optical Coherence Tomography

Katayama, Y., Tanaka, A., Taruya, A., Kashiwagi, M., Nishiguchi, T., Ozaki, Y., Matsuo, Y., Kitabata, H., Kubo, T., Shimada, E., et al. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.312934 · Cited by 39 · see citing works

PPARα Ligands Reduce PCB-Induced Endothelial Activation: Possible Interactions in Inflammation and Atherosclerosis

Arzuaga, X., Reiterer, G., Májková, Z., Kilgore, M. W., Toborek, M. J., & Hennig, B. (2007) · Cardiovascular Toxicology · doi:10.1007/s12012-007-9005-8 · Cited by 36 · see citing works

A Comparative Perspective on Wnt/β-Catenin Signalling in Cell Fate Determination

Garcin, C. L., & Habib, S. J. (2017) · Results and problems in cell differentiation · doi:10.1007/978-3-319-53150-2_15 · Cited by 36 · see citing works

Alterations of anti-inflammatory lipids in plasma from women with chronic widespread pain - a case control study

Stensson, N., Ghafouri, B., Gerdle, B. U. C., & Ghafouri, N. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0505-7 · Cited by 33 · see citing works

The protective effects of the β3 adrenergic receptor agonist BRL37344 against liver steatosis and inflammation in a rat model of high-fat diet-induced nonalcoholic fatty liver disease (NAFLD)

Wang, Z., Li, S., Wang, R., Guo, L., Xu, D., Zhang, T., Xu, Y., Wang, W., Wang, M., Gan, Z., et al. (2020) · Molecular Medicine · doi:10.1186/s10020-020-00164-4 · Cited by 34 · see citing works

Mitochondrial-related proteomic changes during obesity and fasting in mice are greater in the liver than skeletal muscles

Nesteruk, M., Hennig, E. E., Mikuła, M., Karczmarski, J., Dzwonek, A., Goryca, K., Rubel, T., Paziewska, A., Woszczyński, M., Ledwon, J. K., et al. (2013) · Functional & Integrative Genomics · doi:10.1007/s10142-013-0342-3 · Cited by 32 · see citing works

Peroxisome Proliferator-Activated Receptors Associated with Nonalcoholic Fatty Liver Disease

Wang, N., Kong, R., Luo, H., Xu, X., & Lu, J. (2017) · PPAR Research · doi:10.1155/2017/6561701 · Cited by 33 · see citing works

Immunometabolic cross-talk in the inflamed heart

Marelli‐Berg, F. M., & Aksentijević, D. (2019) · Cell Stress · doi:10.15698/cst2019.08.194 · Cited by 34 · see citing works

Regulation of Sexually Dimorphic Expression of Major Urinary Proteins

Penn, D. J., Zala, S. M., & Luzynski, K. C. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.822073 · Cited by 33 · see citing works

The Role of Cannabidiol in Liver Disease: A Systemic Review

Chen, S., & Kim, J.-K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042370 · Cited by 36 · see citing works

Short-term therapy with atorvastatin or fenofibrate does not affect plasma ghrelin, resistin or adiponectin levels in type 2 diabetic patients with mixed hyperlipoproteinaemia

Otto, C., Otto, B., Frost, R. J., Vogeser, M., Pfeiffer, A. F. H., Spranger, J., & Parhofer, K. G. (2007) · Acta Diabetologica · doi:10.1007/s00592-007-0244-8 · Cited by 32 · see citing works

Oleoylethanolamide facilitates PPARα and TFEB signaling and attenuates Aβ pathology in a mouse model of Alzheimer’s disease

Comerota, M. M., Gedam, M., Xiong, W., Jin, F., Deng, L., Wang, M. C., Wang, J., & Zheng, H. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00648-x · Cited by 31 · see citing works

Influence of Genistein on Hepatic Lipid Metabolism in an In Vitro Model of Hepatic Steatosis

Seidemann, L., Krüger, A., Kegel, V., Seehofer, D., & Damm, G. (2021) · Molecules · doi:10.3390/molecules26041156 · Cited by 30 · see citing works

Anti‐Inflammatory and PPAR Transactivational Properties of Flavonoids from the Roots of Sophora flavescens

Quang, T. H., Ngân, N. T. T., Minh, C. V., Kiệm, P. V., Tài, B. H., Nhiệm, N. X., Thảo, N. P., Luyen, B. T. T., Yang, S. Y., & Kim, Y. H. (2012) · Phytotherapy Research · doi:10.1002/ptr.4871 · Cited by 29 · see citing works

Systemic and Distal Repercussions of Liver-Specific Peroxisome Proliferator-Activated Receptor-α Control of the Acute-Phase Response

Mansouri, R. M., Baugé, E., Staels, B., & Gervois, P. P. (2008) · Endocrinology · doi:10.1210/en.2007-1339 · Cited by 62 · see citing works

Fenofibrate, a peroxisome proliferator-activated receptor α-agonist, blocks lipopolysaccharide-induced inflammatory pathways in mouse liver

Won, T. W. (2013) · Korean Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.14701/kjhbps.2013.17.3.89 · Cited by 18 · see citing works

Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1

Delerive, P., De Bosscher, K., Besnard, S., Vanden Berghe, W., Peters, J. M., Gonzalez, F. J., Fruchart, J.-C., Tedgui, A., Haegeman, G., & Staels, B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32048 · Cited by 1,089 · see citing works

Negative Regulation of Human Fibrinogen Gene Expression by Peroxisome Proliferator-activated Receptor α Agonists via Inhibition of CCAAT Box/Enhancer-binding Protein β

Gervois, P. P., Vu‐Dac, N., Kleemann, R., Kockx, M., Dubois, G., Laine, B., Kosykh, V., Fruchart, J., Kooistra, T., & Staels, B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102839200 · Cited by 153 · see citing works

Interleukin-6 inhibition of peroxisome proliferator-activated receptor alpha expression is mediated by JAK2- and PI3K-induced STAT1/3 in HepG2 hepatocyte cells

Chew, G., Myers, S., Shu-Chien, A. C., & Muhammad, T. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1896-z · Cited by 22 · see citing works